Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42 GBX | 0.00% | +16.67% | +82.61% |
May. 20 | Finseta changes name from Cornerstone FS | AN |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 6.996 | 3.256 | 28.32 | 28.32 | - |
Enterprise Value (EV) 2 | 6.996 | 3.256 | 15.22 | 26.69 | 23.42 |
P/E ratio | - | - | 6.12 x | 23.3 x | 11.7 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.63 x | 0.59 x | 1.36 x | 2.11 x | 1.72 x |
EV / Revenue | 2.63 x | 0.59 x | 1.36 x | 1.99 x | 1.42 x |
EV / EBITDA | -4.71 x | -3.25 x | 7.7 x | 12 x | 6.26 x |
EV / FCF | -6 x | -2.17 x | 40.5 x | 28.7 x | 8.06 x |
FCF Yield | -16.7% | -46.1% | 2.47% | 3.48% | 12.4% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 20,278 | 48,036 | 57,417 | 57,417 | - |
Reference price 3 | 0.2900 | 0.0600 | 0.4200 | 0.4200 | 0.4200 |
Announcement Date | 6/30/22 | 5/16/23 | 5/8/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 1.933 | 2.664 | 5.551 | 11.22 | 13.44 | 16.48 |
EBITDA 1 | - | -1.485 | -1.001 | 1.976 | 2.221 | 3.74 |
EBIT 1 | - | -1.661 | -1.463 | 1.253 | 1.636 | 3.039 |
Operating Margin | - | -62.35% | -26.35% | 11.17% | 12.17% | 18.44% |
Earnings before Tax (EBT) 1 | - | - | -6.662 | 1.5 | 1.286 | 2.454 |
Net income 1 | - | - | -6.461 | 2.481 | 1.286 | 2.454 |
Net margin | - | - | -116.38% | 22.11% | 9.57% | 14.89% |
EPS 2 | - | - | - | 0.0376 | 0.0180 | 0.0360 |
Free Cash Flow 1 | - | -1.167 | -1.502 | 0.696 | 0.93 | 2.906 |
FCF margin | - | -43.79% | -27.06% | 6.18% | 6.92% | 17.63% |
FCF Conversion (EBITDA) | - | - | - | 42.41% | 41.87% | 77.7% |
FCF Conversion (Net income) | - | - | - | 118.77% | 72.32% | 118.42% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 6/8/21 | 6/30/22 | 5/16/23 | 5/8/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | - | - | - | 0.12 | 1.64 | 4.91 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | -1.17 | -1.5 | 0.7 | 0.93 | 2.91 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | 0.02 | 0.51 | 0.47 | 1.16 | 0.7 |
Capex / Sales | - | 0.76% | 9.11% | 4.13% | 8.66% | 4.24% |
Announcement Date | 6/8/21 | 6/30/22 | 5/16/23 | 5/8/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+82.61% | 30.66M | |
+18.18% | 343B | |
+28.56% | 227B | |
+9.11% | 160B | |
+12.90% | 57.58B | |
+17.41% | 33.97B | |
+5.56% | 31.14B | |
+160.76% | 29.36B | |
+33.61% | 21.75B | |
+46.11% | 14.73B |
- Stock Market
- Equities
- FIN Stock
- Financials Finseta Plc